Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.56 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TOP2A | P11388 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.45 |
| ▸ | SI | P14410 | 1/20 | 0.45 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | PPID | Q08752 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL11727486 | 1.00 | CYP4F2 (0.56) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A | |
| Toluene SCHEMBL1233802 | 0.89 | CYP4F2 (0.56) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A | |
| Benzene SCHEMBL8074988 | 0.88 | MGAM (0.56) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A | |
| Toluene SCHEMBL8513838 | 0.87 | SMN1; SMN2 (0.54) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A | |
| Toluene SCHEMBL28096369 | 0.87 | CYP4F2 (0.61) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A | |
| Toluene SCHEMBL10779605 | 0.86 | CYP4F2 (0.57) | CYP4F2CYP4A11SMN1; SMN2TOP2AALDH1A1 | |
| Toluene SCHEMBL27711158 | 0.85 | CYP1A2 (0.55) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A | |
| Toluene SCHEMBL242077 | 0.85 | SMN1; SMN2 (0.57) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A | |
| Toluene SCHEMBL10526783 | 0.85 | CYP4F2 (0.49) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A | |
| Toluene SCHEMBL9811805 | 0.85 | CYP4F2 (0.50) | CYP4F2CYP4A11SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116953144-A | Thin-layer chromatography identification method of Dan-zedoary Fukang decoction | 云南圣科药业有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116429962-A | Thin-layer identification chromatography method for feather cockscomb seed and fried feather cockscomb seed formula particles | 四川新绿色药业科技发展有限公司 | 2023-07-14 | — | — | CN | claimed |
| US-20230181666-A1 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF | BEIJING HANDIAN PHARMACEUTICAL CO., LTD. (CN) | 2023-06-15 | — | — | US | claimed |
| EP-4147708-A1 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF | Beijing Handian Pharmaceutical Co., Ltd. (CN) | 2023-03-15 | — | — | EP | claimed |
| CN-112274620-A | Traditional Chinese medicine composition for treating novel coronavirus pneumonia, preparation method, detection method and application thereof | 北京汉典制药有限公司 | 2021-01-29 | — | — | CN | claimed |
| CN-109061027-B | Method for synthesizing phenolic antioxidant by HPTLC-biological development screening of oil | 江南大学 | 2020-10-09 | — | — | CN | claimed |
| CN-111407877-A | Traditional Chinese medicine composition for treating novel coronavirus pneumonia, preparation method, detection method and application thereof | 北京汉典制药有限公司 | 2020-07-14 | — | — | CN | claimed |
| CN-109061027-A | The method of HPTLC- biological developing screening oil synthesis phenol antioxidant | 江南大学 | 2018-12-21 | — | — | CN | claimed |
| CN-106093269-A | A kind of quality determining method of Kuiyang Capsules | 江苏七O七天然制药有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-103330758-A | Peony and liquorice soup formula granule, preparation method and detection method of peony and liquorice soup formula granule | KANGMEI PHARMACEUTICAL CO LTD | 2013-10-02 | — | — | CN | claimed |
| CN-102274477-B | Preparation method of sugar-free granules for treating wind-cold type common cold | Guangdong yifang pharmaceutical co ltd | 2013-08-07 | — | — | CN | claimed |
| CN-101897886-A | Quality control method of trichogenous gel | BEIJING INCREASE PHARM CO LTD | 2010-12-01 | — | — | CN | claimed |
| CN-101632804-A | Quality control method for wind-dispelling heat-dissipating capsules | BEIJING ASIA EAST BIO PHARM CO | 2010-01-27 | — | — | CN | claimed |
| CN-101274036-A | Method for testing quality criteria of conghuang preparation for tonifying kidney | MASSON GROUP CO LTD (CN) | 2008-10-01 | — | — | CN | claimed |
| CN-101264125-A | Natural medicine oral preparation for treating dropsy | TIANJIN DANXI INST (CN) | 2008-09-17 | — | — | CN | claimed |
| CN-101264124-A | Natural medicine colonic capsules for treating hemorrhoidal disease | TIANJIN DANXI INST (CN) | 2008-09-17 | — | — | CN | claimed |
| CN-101264123-A | Natural medicine dropping pills for treating hemorrhoidal disease | TIANJIN DANXI INST (CN) | 2008-09-17 | — | — | CN | claimed |
| CN-1923263-A | Traditional Chinese medicine composition, its preparing method and quality controlling means | WU YIFANG (CN) | 2007-03-07 | — | — | CN | claimed |
| CN-1868534-A | Medicine composition, its prepn. method, quality control method | WU YIFANG (CN) | 2006-11-29 | — | — | CN | claimed |
| CN-114236034-B | Method for detecting asiatic toddalia root blood medicinal material | 贵州恒霸药业有限责任公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116953144-A | Thin-layer chromatography identification method of Dan-zedoary Fukang decoction | 云南圣科药业有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-116726068-A | Method for extracting flavonoid compounds from common selfheal fruit-spike | 贵阳学院 | 2023-09-12 | — | — | CN | disclosed |
| CN-116429962-A | Thin-layer identification chromatography method for feather cockscomb seed and fried feather cockscomb seed formula particles | 四川新绿色药业科技发展有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116429962-A | Thin-layer identification chromatography method for feather cockscomb seed and fried feather cockscomb seed formula particles | 四川新绿色药业科技发展有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116399998-A | Multi-information rapid TLC integral identification method of dendrobium candidum stomach-nourishing particles | 浙江工业大学 | 2023-07-07 | — | — | CN | disclosed |
| US-20230181666-A1 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF | BEIJING HANDIAN PHARMACEUTICAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| CN-112274620-B | Traditional Chinese medicine composition for treating novel coronavirus pneumonia, preparation method, detection method and application thereof | 北京汉典制药有限公司 | 2023-03-17 | — | — | CN | disclosed |
| EP-4147708-A1 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF | Beijing Handian Pharmaceutical Co., Ltd. (CN) | 2023-03-15 | — | — | EP | disclosed |
| CN-114236034-A | Detection method of toddalia asiatica medicinal material | 贵州恒霸药业有限责任公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-111983106-B | Quality control method of dampness-resolving and toxin-vanquishing composition | 广东一方制药有限公司 | 2021-06-22 | — | — | CN | disclosed |
| CN-112274620-A | Traditional Chinese medicine composition for treating novel coronavirus pneumonia, preparation method, detection method and application thereof | 北京汉典制药有限公司 | 2021-01-29 | — | — | CN | disclosed |
| CN-112067738-A | Method for identifying dampness-resolving toxin-vanquishing composition | 广东一方制药有限公司 | 2020-12-11 | — | — | CN | disclosed |
| CN-111983106-A | Quality control method of dampness-resolving and toxin-vanquishing composition | 广东一方制药有限公司 | 2020-11-24 | — | — | CN | disclosed |
| CN-109061027-B | Method for synthesizing phenolic antioxidant by HPTLC-biological development screening of oil | 江南大学 | 2020-10-09 | — | — | CN | disclosed |
| CN-111407877-A | Traditional Chinese medicine composition for treating novel coronavirus pneumonia, preparation method, detection method and application thereof | 北京汉典制药有限公司 | 2020-07-14 | — | — | CN | disclosed |
| EP-2601203-B2 | FATTY ACID ESTERS OF CAROTENOID GLUCOSIDES AS COLOURING AGENTS FOR FOODSTUFFS | ROYAL HOLLOWAY & BEDFORD NEW COLLEGE (GB) | 2020-03-25 | — | — | EP | disclosed |
| CN-109061027-A | The method of HPTLC- biological developing screening oil synthesis phenol antioxidant | 江南大学 | 2018-12-21 | — | — | CN | disclosed |
| EP-2601203-B1 | FATTY ACID ESTERS OF CAROTENOID GLUCOSIDES AS COLOURING AGENTS FOR FOODSTUFFS | ROYAL HOLLOWAY & BEDFORD NEW COLLEGE (GB) | 2017-02-08 | — | — | EP | disclosed |
| CN-106093269-A | A kind of quality determining method of Kuiyang Capsules | 江苏七O七天然制药有限公司 | 2016-11-09 | — | — | CN | disclosed |
| CN-104762034-B | Low VOC polyacrylate pressure-sensitive sticks agent and preparation method thereof | 深圳日高胶带新材料有限公司 | 2016-09-28 | — | — | CN | disclosed |
| EP-1700922-B1 | 3-Substituted 5-Nitroindole derivatives and labeled oligonucleotide probes containing them | ROCHE DIAGNOSTICS GMBH (DE) | 2016-08-24 | — | — | EP | disclosed |
| CN-105816700-A | External application ointment for treating scalds and burns | 广西大学 | 2016-08-03 | — | — | CN | disclosed |
| EP-1842923-B1 | Methanesulfonylaminoindole derivatives and labeled oligonucleotide probes containing them | ROCHE DIAGNOSTICS GMBH (DE) | 2015-07-15 | — | — | EP | disclosed |
| CN-104762034-A | Low-VOC polyacrylate pressure-sensitive adhesive and preparation method thereof | SHENZHEN NIKTO TAPE NEW MATERIAL CO LTD | 2015-07-08 | — | — | CN | disclosed |
| CN-103330758-A | Peony and liquorice soup formula granule, preparation method and detection method of peony and liquorice soup formula granule | KANGMEI PHARMACEUTICAL CO LTD | 2013-10-02 | — | — | CN | disclosed |
| CN-102274477-B | Preparation method of sugar-free granules for treating wind-cold type common cold | Guangdong yifang pharmaceutical co ltd | 2013-08-07 | — | — | CN | disclosed |
| EP-2601203-A1 | FATTY ACID ESTERS OF CAROTENOID GLUCOSIDES AS COLOURING AGENTS FOR FOODSTUFFS | Royal Holloway And Bedford New College (GB) | 2013-06-12 | — | — | EP | disclosed |
| US-8318785-B2 | Pharmaceutical compounds | ORION CORPORATION (FI) | 2012-11-27 | — | — | US | disclosed |
| CN-102441149-A | A Chinese medicinal composition for treating alopecia, and its preparation method and quality control technology | ANHUI INST OF TCM & NATURAL DRUG RES CO LTD | 2012-05-09 | — | — | CN | disclosed |
| WO-2012017199-A1 | FATTY ACID ESTERS OF CAROTENOID GLUCOSIDES AS COLOURING AGENTS FOR FOODSTUFFS | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE ET AL (GB) | 2012-02-09 | — | — | WO | disclosed |
| CN-102274477-A | Sugar-free granules for treating wind-cold type common cold and preparation method thereof | — | 2011-12-14 | — | — | CN | disclosed |
| CN-1923263-B | Traditional Chinese medicine composition, its preparing method and quality controlling means | YIFANG WU | 2011-09-21 | — | — | CN | disclosed |
| CN-1985901-B | Chinese medicine composition for promoting blood circulation and dredging collaterals and its preparing method and use | JIANGSU ZEUKOV PHARMACEUTICAL S & T INC | 2011-05-04 | — | — | CN | disclosed |
| US-20110086852-A2 | PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2011-04-14 | — | — | US | disclosed |
| CN-101897741-A | Quality control method for asiaticoside gel | BEIJING INCREASE PHARM CO LTD | 2010-12-01 | — | — | CN | disclosed |
| CN-101897886-A | Quality control method of trichogenous gel | BEIJING INCREASE PHARM CO LTD | 2010-12-01 | — | — | CN | disclosed |
| EP-1783129-B1 | SPIROPIPERIDYL RIFAMYCINS FOR THE TREATMENT OF MICROBACTERIAL INFECTIONS | UNIV OVIEDO (ES) | 2010-10-13 | — | — | EP | disclosed |
| EP-1910325-B1 | NEW PHARMACEUTICAL COMPOUNDS | ORION CORP (FI) | 2010-10-06 | — | — | EP | disclosed |
| US-7759470-B2 | Labeling reagent | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2010-07-20 | — | — | US | disclosed |
| US-7759469-B2 | substituted indole nucleosides as both terminal as well as internal building blocks of labeled oligonucleotide probes for the detection, analysis and quantitation of nucleic acids; nucleoside with a 3-substituted methanesulfonylamino indole as nucleobase | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2010-07-20 | — | — | US | disclosed |
| US-7695980-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2010-04-13 | — | — | US | disclosed |
| CN-101632804-A | Quality control method for wind-dispelling heat-dissipating capsules | BEIJING ASIA EAST BIO PHARM CO | 2010-01-27 | — | — | CN | disclosed |
| US-20090209532-A1 | PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2009-08-20 | — | — | US | disclosed |
| CN-100515445-C | Quality control method for traditional Chinese medicine preparation for treating generalized anxiety | GUIZHOU TONGJITANG PHARMACEUTI (CN) | 2009-07-22 | — | — | CN | disclosed |
| CN-101439172-A | Chinese medicinal composition and preparation method thereof and quality control method | BEIJING ASIA EAST BIO PHARM CO (CN) | 2009-05-27 | — | — | CN | disclosed |
| CN-100434092-C | Prescription containing sweet clover component and its formulation | TIANJIN KANGHONG PHARMACEUTICA (CN) | 2008-11-19 | — | — | CN | disclosed |
| CN-101274036-A | Method for testing quality criteria of conghuang preparation for tonifying kidney | MASSON GROUP CO LTD (CN) | 2008-10-01 | — | — | CN | disclosed |
| EP-1910325-A2 | NEW PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2008-04-16 | — | — | EP | disclosed |
| EP-1842923-A1 | Methanesulfonylaminoindole derivatives and labeled oligonucleotide probes containing them. | Roche Diagnostics GmbH (DE) | 2007-10-10 | — | — | EP | disclosed |
| US-20070196852-A1 | Labeling reagent | ROCHE DIAGNOSTICS GMBH (DE) | 2007-08-23 | — | — | US | disclosed |
| CN-1985901-A | Chinese medicine composition for promoting blood circulation and dredging collaterals and its preparing method and use | ZHONGKANG MEDICINE SCI TECH CO (CN) | 2007-06-27 | — | — | CN | disclosed |
| EP-1783129-A1 | SPIROPIPERIDYL RIFAMYCINS FOR THE TREATMENT OF MICROBACTERIAL INFECTIONS | UNIVERSIDAD DE OVIEDO (ES) | 2007-05-09 | — | — | EP | disclosed |
| CN-1923263-A | Traditional Chinese medicine composition, its preparing method and quality controlling means | WU YIFANG (CN) | 2007-03-07 | — | — | CN | disclosed |
| US-20070050865-A1 | Polynucleotide encoding 2-hydorxyisoflavanone dehydratase and application of the same | NIHON UNIVERSITY (JP) | 2007-03-01 | — | — | US | disclosed |
| WO-2007010085-A2 | NEW PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2007-01-25 | — | — | WO | disclosed |
| CN-1868534-A | Medicine composition, its prepn. method, quality control method | WU YIFANG (CN) | 2006-11-29 | — | — | CN | disclosed |
| EP-1186613-B1 | New reagent for labelling nucleic acids | ROCHE DIAGNOSTICS GMBH (DE) | 2006-11-22 | — | — | EP | disclosed |
| CN-1843432-A | Quality control method for traditional Chinese medicine formulation for treating generalized anxiety | GUIZHOU TONGJITANG PHARMACEUTI (CN) | 2006-10-11 | — | — | CN | disclosed |
| US-20060216736-A1 | Labeling reagent | ROCHE DIAGNOSTICS OPERTIONS, INC. (US) | 2006-09-28 | — | — | US | disclosed |
| EP-1700922-A2 | Nitroindole derivatives and labeled oligonucleotide probes containing them | Roche Diagnostics GmbH (DE) | 2006-09-13 | — | — | EP | disclosed |
| US-20060199833-A1 | Novel chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2006-09-07 | — | — | US | disclosed |
| EP-1658495-A1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | Roche Diagnostics GmbH (DE) | 2006-05-24 | — | — | EP | disclosed |
| CN-1768775-A | Prescription containing sweet clover component and its formulation | TIANJIN KANGHONG PHARMACEUTICA (CN) | 2006-05-10 | — | — | CN | disclosed |
| US-6875850-B2 | Reagent for labelling nucleic acids | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2005-04-05 | — | — | US | disclosed |
| WO-2005015214-A1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2005-02-17 | — | — | WO | disclosed |
| US-20050009898-A1 | New substituted indolinones, their manufacture and their use as medicaments | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2005-01-13 | — | — | US | disclosed |
| US-6815449-B2 | AN IMMUNOSUPPRESSANTS FOR TREATING AUTOIMMUNE DISEASES, ANTIALLERGIC AGENTS, ANTITUMOR AGENTS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-11-09 | — | — | US | disclosed |
| EP-1097934-B1 | LK6-A DERIVATIVES | KYOWA HAKKO KOGYO KK (JP) | 2004-10-13 | — | — | EP | disclosed |
| US-6794395-B1 | Substituted indolinones, their manufacture and their use as medicaments | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-09-21 | — | — | US | disclosed |
| US-6756492-B1 | Nucleoside derivatives with photo-unstable protective groups | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUND DES OFFENTLICHEN RECHTS (DE) | 2004-06-29 | — | — | US | disclosed |
| EP-0797447-B1 | HUMAN CANCER INHIBITORY PENTAPEPTIDE HETEROCYCLIC AND HALOPHENYL AMIDES | UNIV ARIZONA (US) | 2004-03-03 | — | — | EP | disclosed |
| US-20030181722-A1 | LK6-A derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-09-25 | — | — | US | disclosed |
| US-6613774-B1 | Alkaloids used as immunosuppressants, antiproliferative or antitumor agents for therapy of autoimmune diseases or allergies | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-09-02 | — | — | US | disclosed |
| US-20020110691-A1 | Label bound via an amide bond and a linker to a residue of the molecule characterized in that the N atom of the amide bond and the label are linked together directly by a covalent bond; phosphoramidites or reactive supports | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2002-08-15 | — | — | US | disclosed |
| US-20020099186-A1 | Processes for the preparation of alphaGal(1-3)betaGal(1-4)Glc-OR | SYNSORB BIOTECH, INC. (CA) | 2002-07-25 | — | — | US | disclosed |
| EP-1186613-A1 | New reagent for labelling nucleic acids | Roche Diagnostics GmbH (DE) | 2002-03-13 | — | — | EP | disclosed |
| EP-1097934-A1 | LK6-A DERIVATIVES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2001-05-09 | — | — | EP | disclosed |
| US-6197963-B1 | TETRAHYDROPYRAN DERIVATIVES; PROTEIN G, SOMATOSTATIN, AND NATURAL KILLER CELL RECEPTOR ANTAGONISTS OR MIMETICS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2001-03-06 | — | — | US | disclosed |
| EP-0770614-B1 | Pyrrolo(4,3,2-de)quinoline derivative | KYOWA HAKKO KOGYO KK (JP) | 2000-12-06 | — | — | EP | disclosed |
| EP-0675733-B1 | PEPTIDE-CARBOHYDRATE CONJUGATES GENERATING T-CELL IMMUNITY | ASTRAZENECA AB (SE) | 2000-12-06 | — | — | EP | disclosed |
| US-6114345-A | Phenylsubstituted 4-azasteroid fluoroderivatives | PHARMACIA & UPJOHN, S.P.A. (IT) | 2000-09-05 | — | — | US | disclosed |
| EP-0902790-B1 | PROCESS FOR PREPARING STEROIDS HAVING A CARBOXAMIDE SIDE-CHAIN | PHARMACIA & UPJOHN SPA (IT) | 2000-08-16 | — | — | EP | disclosed |
| US-6033669-A | IMMUNOGENIC CONJUGATE COMPRISES,(I) A PEPTIDE COMPONENT CAPABLE OF BINDING A MHC CLASS I MOLECULE; AND (II) A CARBOHYDRATE COMPONENT HAVING THE IMMUNOGENIC SPECIFICITY OF SAID CARBOHYDRATE STRUCTURE. | ASTRA AKTIEBOLAG (SE) | 2000-03-07 | — | — | US | disclosed |
| EP-0793671-B1 | PHENYLSUBSTITUTED 4-AZASTEROID FLUORODERIVATIVES | PHARMACIA & UPJOHN SPA (IT) | 2000-02-09 | — | — | EP | disclosed |
| EP-0797447-A4 | HUMAN CANCER INHIBITORY PENTAPEPTIDE HETEROCYCLIC AND HALOPHENYL AMIDES | UNIV ARIZONA (US) | 1999-09-29 | — | — | EP | disclosed |
| US-5922728-A | N-(PHENYLPERFLUOROALKYL)-3-OXO-4-AZA-5ALPHA-(ANDROSTANE OR ANDROST-1-ENE)-17BETA-CARBOXAMIDE DERIVATIVES, METHODS OF SYNTHESIZING THEM AND THEIR USE FOR TREATING PROSTATIC HYPERPLASIA | PHARMACIA & UPJOHN, S.P.A. (IT) | 1999-07-13 | — | — | US | disclosed |
| US-5910579-A | Processes for the preparation of αGal(1->4)βGal (1->4) Glc-OR | SYNSORB BIOTECH INC. (CA) | 1999-06-08 | — | — | US | disclosed |
| EP-0902790-A1 | PROCESS FOR PREPARING STEROIDS HAVING A CARBOXAMIDE SIDE-CHAIN | PHARMACIA & UPJOHN S.p.A. (IT) | 1999-03-24 | — | — | EP | disclosed |
| US-5877170-A | VIRICIDES | DUPONT PHARMACEUTICALS COMPANY (US) | 1999-03-02 | — | — | US | disclosed |
| US-5866700-A | Solid-phase synthesis of oligoribonucleotides | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-02-02 | — | — | US | disclosed |
| US-5843955-A | Compound LK6-A | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-12-01 | — | — | US | disclosed |
| US-5817879-A | PEPTIDE ANTAGONIST | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1998-10-06 | — | — | US | disclosed |
| US-5811512-A | BINDING TO G-PROTEIN-LINKED RECEPTORS, SUBSTANCE P RECEPTOR; HORMONE INHIBITORS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1998-09-22 | — | — | US | disclosed |
| US-5807559-A | COMPLEX OF CARBOHYDRATE AND PEPTIDE | ASTRA AKTIEBOLAG (SE) | 1998-09-15 | — | — | US | disclosed |
| EP-0728007-A4 | NON-PEPTIDE PEPTIDOMIMETICS | UNIV PENNSYLVANIA (US) | 1998-09-02 | — | — | EP | disclosed |
| US-5760073-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-06-02 | — | — | US | disclosed |
| WO-1997040062-A1 | PROCESS FOR PREPARING STEROIDS HAVING A CARBOXAMIDE SIDE-CHAIN | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-10-30 | — | — | WO | disclosed |
| EP-0797447-A1 | HUMAN CANCER INHIBITORY PENTAPEPTIDE HETEROCYCLIC AND HALOPHENYL AMIDES | ARIZONA BOARD OF REGENTS (US) | 1997-10-01 | — | — | EP | disclosed |
| EP-0793671-A1 | PHENYLSUBSTITUTED 4-AZASTEROID FLUORODERIVATIVES | PHARMACIA & UPJOHN S.p.A. (IT) | 1997-09-10 | — | — | EP | disclosed |
| US-5663149-A | ANTICARCINOGENIC AGENTS RELATED TO DOLASTATIN | ARIZONA BOARD OF REGENTS ACTING ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 1997-09-02 | — | — | US | disclosed |
| WO-1997028172-A1 | NON-PEPTIDE PEPTIDOMIMETICS AND RELATED CYCLIC HEXAPEPTIDES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1997-08-07 | — | — | WO | disclosed |
| US-5652358-A | Solid-phase synthesis of oligoribonucleotides | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-07-29 | — | — | US | disclosed |
| EP-0782582-A1 | EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5$g(a)-ANDROST-1-ENE-17$g(b)-CARBOXAMIDE | PHARMACIA & UPJOHN S.p.A. (IT) | 1997-07-09 | — | — | EP | disclosed |
| EP-0770614-A2 | Pyrrolo(4,3,2-de)quinoline derivative | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1997-05-02 | — | — | EP | disclosed |
| WO-1997010257-A1 | PHENYLSUBSTITUTED 4-AZASTEROID FLUORODERIVATIVES | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-03-20 | — | — | WO | disclosed |
| WO-1997004002-A1 | EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5α-ANDROST-1-ENE-17β-CARBOXAMIDE | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-02-06 | — | — | WO | disclosed |
| US-5554771-A | 2-deoxy derivatives of N-acetyl neuraminic acid and their preparation | G. D. SEARLE & CO. (US) | 1996-09-10 | — | — | US | disclosed |
| US-5552534-A | COMPOUNDS FOR CROSS REACTION WITH PEPTIDES FOR BINDING G PROTEIN | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1996-09-03 | — | — | US | disclosed |
| EP-0728007-A1 | NON-PEPTIDE PEPTIDOMIMETICS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1996-08-28 | — | — | EP | disclosed |
| US-5550251-A | CROSSREACTIVE WITH PEPTIDES BOUND BY G-PROTEIN LINKED RECEPTORS; USED AS THERAPEUTICAL, DIAGNOSTIC, AND PROPHYLITIC | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1996-08-27 | — | — | US | disclosed |
| WO-1996018408-A1 | HUMAN CANCER INHIBITORY PENTAPEPTIDE HETEROCYCLIC AND HALOPHENYL AMIDES | ARIZONA BOARD OF REGENTS (US) | 1996-06-20 | — | — | WO | disclosed |
| US-5525480-A | USED FOR DETERMINATION OF HYDROLASES; COLORIMETRIC ANALYSIS | BOEHRINGER MANNHEIM GMBH (DE) | 1996-06-11 | — | — | US | disclosed |
| EP-0675733-A1 | PEPTIDE-CARBOHYDRATE CONJUGATES GENERATING T-CELL IMMUNITY | Astra Aktiebolag (SE) | 1995-10-11 | — | — | EP | disclosed |
| US-5457200-A | Oxidative coupling reactions for determination of hydrogen peroxide | BOEHRINGER MANNHEIM (DE) | 1995-10-10 | — | — | US | disclosed |
| WO-1995011686-A1 | NON-PEPTIDE PEPTIDOMIMETICS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1995-05-04 | — | — | WO | disclosed |
| US-5391482-A | Method and diagnostic agent for enzyme substrate stabilization using 1-arylsemicarbazides | BOEHRINGER MANNHEIM GMBH (DE) | 1995-02-21 | — | — | US | disclosed |
| US-5334505-A | For colorimetric determination of hydrolases | BOEHRINGER MANNHEIM GMBH (DE) | 1994-08-02 | — | — | US | disclosed |
| US-5314887-A | Cardiovascular disorders | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-05-24 | — | — | US | disclosed |
| US-5292669-A | Chromogenic agent, oxidizer | BOEHRINGER MANNHEIM GMBH (DE) | 1994-03-08 | — | — | US | disclosed |
| WO-1993021948-A1 | PEPTIDE-CARBOHYDRATE CONJUGATES GENERATING T-CELL IMMUNITY | ASTRA AKTIEBOLAG (SE) | 1993-11-11 | — | — | WO | disclosed |
| US-5239091-A | 2-deoxy derivatives of N-acetyl neuraminic acid and their preparation | G. D. SEARLE & CO. (US) | 1993-08-24 | — | — | US | disclosed |
| US-5234818-A | Detecting hydrogen peroxide, peroxidase by oxidative coupling with electron-rich aromatic compound | BOEHRINGER MANNHEIM GMBH (DE) | 1993-08-10 | — | — | US | disclosed |
| EP-0530980-A1 | Neristatin 1 and a composition comprising the compound for the treatment of lymphocytic leukemia | ARIZONA BOARD OF REGENTS (US) | 1993-03-10 | — | — | EP | disclosed |
| US-5166148-A | Treatment of congestive heart failure | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-11-24 | — | — | US | disclosed |
| WO-1992000741-A1 | 2-AMINO-1,4-DIHYDROPYRIDINE DERIVATIVES WITH CALCIUM AGONIST AND ALPHA1-ANTAGONIST ACTIVITY | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-01-23 | — | — | WO | disclosed |
| US-5068325-A | Dopaminergic systems as hypotensives, sedatives, antitussives and/or antiphlogistics | KARL THOMAE GMBH (DE) | 1991-11-26 | — | — | US | disclosed |
| EP-0148883-B1 | ALLOPURINOL PRODRUGS | A/S GEA Farmaceutisk Fabrik (DK) | 1990-02-14 | — | — | EP | disclosed |
| US-4694006-A | Acyl- or acyloxymethyl-allopurinol prodrugs | A/S GEA (DK) | 1987-09-15 | — | — | US | disclosed |
| US-4668622-A | Phenolsulphonphthaleinyl-β-D-galactosides and diagnostic agents containing them | BOEHRINGER MANNHEIM GMBH (DE) | 1987-05-26 | — | — | US | disclosed |
| US-4665023-A | MEDICAL DIAGNOSIS | BOEHRINGER MANNHEIM GMBH (DE) | 1987-05-12 | — | — | US | disclosed |
| EP-0148883-A1 | ALLOPURINOL PRODRUGS. | GEA AS (DK) | 1985-07-24 | — | — | EP | disclosed |
| WO-1985000368-A1 | ALLOPURINOL PRODRUGS | A/S GEA (DK) | 1985-01-31 | — | — | WO | disclosed |
| US-4472422-A | Antihypertensive 4,5-diaryl-α-polyfluoro-alkyl-1H-imidazole-2-methanamines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-09-18 | — | — | US | disclosed |
| US-4472422-A | Antihypertensive 4,5-diaryl-α-polyfluoro-alkyl-1H-imidazole-2-methanamines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060199833-A1 | Novel chemiluminescent compounds and their use | LANCL1, LPO, HLCS | CYP4F2 324/4885CYP4A11 381/4885SMN1; SMN2 4827/4885 |
| US-20050009898-A1 | New substituted indolinones, their manufacture and their use as medicaments | CCNE1, CDK1, CCNI | CYP4F2 1152/4885CYP4A11 506/4885SMN1; SMN2 4537/4885 |
| US-20020099186-A1 | Processes for the preparation of alphaGal(1-3)betaGal(1-4)Glc-OR | B3GAT3, ST6GAL1, B4GALT1 | CYP4F2 1765/4885CYP4A11 997/4885SMN1; SMN2 3411/4885 |
| US-20090209532-A1 | PHARMACEUTICAL COMPOUNDS | COMT, CYP2C19, UGT1A1 | CYP4F2 35/4885CYP4A11 39/4885SMN1; SMN2 1281/4885 |
| US-20060216736-A1 | Labeling reagent | DUT, NUDT1, NT5C2 | CYP4F2 969/4885CYP4A11 2160/4885SMN1; SMN2 1298/4885 |
| US-20070196852-A1 | Labeling reagent | INMT, RNGTT, DUT | CYP4F2 1628/4885CYP4A11 2468/4885SMN1; SMN2 2786/4885 |
| US-20110086852-A2 | PHARMACEUTICAL COMPOUNDS | COMT, CYP2C19, CYP3A4 | CYP4F2 30/4885CYP4A11 24/4885SMN1; SMN2 2315/4885 |
| US-20030181722-A1 | LK6-A derivatives | PBK, CDK6, KLK6 | CYP4F2 2310/4885CYP4A11 2947/4885SMN1; SMN2 4580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.